Molecular characterization of Escherichia coli isolates from patients with urinary tract infections in Palestine

Journal of Medical Microbiology

Volumn 63, Issue PART 2, 2014, Pages 229-234

  Adwan, Kamel ^a   Jarrar, Naser ^a   Abu Hijleh, Awni ^a   Adwan, Ghaleb ^a   Awwad, Elena ^b  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

^b Ministry of Agriculture   (Palestine)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE CTX M; BETA LACTAMASE TEM 1; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DNA SEQUENCE; ESCHERICHIA COLI; GENOTYPE; HUMAN; MULTICENTER STUDY; NONHUMAN; PALESTINE; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; URINALYSIS; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CLUSTER ANALYSIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS;

EID: 84893017087     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.067140-0     Document Type: Article

References (25)

1. Akpaka, P. E., Legall, B. & Padman, J. (2010). Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E. coli from Trinidad and Tobago. West Indian Med J 59, 591-596.
2. Al-Assil, B., Mahfoud, M. & Hamzeh, A. R. (2013). Resistance trends and risk factors of extended-spectrum b-lactamases in Escherichia coli infections in Aleppo, Syria. Am J Infect Control 41, 597-600.
3. Baral, P., Neupane, S., Marasini, B. P., Ghimire, K. R., Lekhak, B. & Shrestha, B. (2012). High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal. BMC Res Notes 5, 38.
4. Chakupurakal, R., Ahmed, M., Sobithadevi, D. N., Chinnappan, S. & Reynolds, T. (2010). Urinary tract pathogens and resistance pattern. J Clin Pathol 63, 652-654.
5. CLSI. (2013). Performance Standards for Antimicrobial Susceptibility Testing; 23rd Informational Supplement M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Harley, J. P. & Prescott, L. M. (2002). Laboratory Exercises in Microbiology, 5th edn, pp. 37-237. Boston, MA: McGraw-Hill Publishers.
7. Karlowsky, J. A., Lagacé-Wiens, P. R., Simner, P. J., De Corby, M. R., Adam, H. J., Walkty, A., Hoban, D. J. & Zhanel, G. G. (2011). Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob Agents Chemother 55, 3169-3175.
8. Khanna, N., Boyes, J., Lansdell, P. M., Hamouda, A. & Amyes, S.G. (2012). Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-b-lactamase-producing Enterobac-teriaceae in Glasgow, Scotland. J Antimicrob Chemother 67, 573-577.
9. Lee, S., Yu, J. K., Park, K., Oh, E. J., Kim, S. Y. & Park, Y. J. (2010). Phylogenetic groups and virulence factors in pathogenic and commensal strains of Escherichia coli and their association with blaCTX-M. Ann Clin Lab Sci 40, 361-367.
10. Leflon-Guibout, V., Jurand, C., Bonacorsi, S., Espinasse, F., Guelfi, M. C., Duportail, F., Heym, B., Bingen, E. & Nicolas-Chanoine, M. H. (2004). Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 48, 3736-3742.
11. Livermore, D. M. & Hawkey, P. M. (2005). CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 56, 451-454.
12. Ma, K. L. & Wang, C. X. (2013). Analysis of the spectrum and antibiotic resistance of uropathogens in vitro: results based on a retrospective study from a tertiary hospital. Am J Infect Control 41, 601-606.
13. Mendonça, N., Leitão, J., Manageiro, V., Ferreira, E. & Caniça, M. (2007). Spread of extended-spectrum b-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother 51, 1946-1955.
14. Mukherjee, M., Basu, S., Mukherjee, S. K. & Majumder, M. (2013). Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E. coli which were isolated from hospitalized patients in Kolkata, India. J Clin Diagn Res 7, 449-453.
15. Murugan, K., Savitha, T. & Vasanthi, S. (2012). Retrospective study of antibiotic resistance among uropathogens from rural teaching hospital, Tamilnadu, India. Asian Pac J Trop Dis 2, 375-380.
16. Naseer, U. & Sundsfjord, A. (2011). The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist 17, 83-97.
17. Peirano, G. & Pitout, J. D. (2010). Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25: H4. Int J Antimicrob Agents 35, 316-321.
18. Pitout, J. D., Laupland, K. B., Church, D. L., Menard, M. L. & Johnson, J. R. (2005). Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 49, 4667-4670.
19. Rakotonirina, H. C., Garin, B., Randrianirina, F., Richard, V., Talarmin, A. & Arlet, G. (2013). Molecular characterization of multidrug-resistant extended-spectrum b-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar. BMC Microbiol 13, 85.
20. Smet, A., Martel, A., Persoons, D., Dewulf, J., Heyndrickx, M., Claeys, G., Lontie, M., Van Meensel, B., Herman, L. & other authors (2010). Characterization of extended-spectrum b-lacta-mases produced by Escherichia coli isolated from hospitalized and non-hospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 16, 129-134.
21. Takahashi, S. & Nagano, Y. (1984). Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. J Clin Microbiol 20, 608-613.
22. Vaidya, V. K. (2011). Horizontal transfer of antimicrobial resistance by extended-spectrum b lactamase-producing Enterobacteriaceae. J Lab Physicians 3, 37-42.
23. Wollheim, C., Guerra, I. M. F., Conte, V. D., Hoffman, S. P., Schreiner, F. J., Delamare, A. P. L., Barth, A. L., Echeverrigaray, S. & da Costa, S. O. P. (2011). Nosocomial and community infections due to class A extended-spectrum b-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil. Braz J Infect Dis 15, 138-143.
24. Xiao, Y. H., Giske, C. G., Wei, Z. Q., Shen, P., Heddini, A. & Li, L. J. (2011). Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat 14, 236-250.
25. Zhang, Y., Yang, J., Ye, L., Luo, Y., Wang, W., Zhou, W., Cui, Z. & Han, L. (2012). Characterization of clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates, 2007-2009, China. Microb Drug Resist 18, 465-470.